Vfend Special Investigation For Prophylaxis
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Voriconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions
- Sponsors Pfizer
- 23 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 01 Mar 2016 Planned End Date changed from 1 Dec 2018 to 1 Jun 2019 as reported by ClinicalTrials.gov.
- 01 Mar 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Jun 2019 as reported by ClinicalTrials.gov.